Improving on estimates of the potential relative harm to health from using modern ENDS (vaping) compared to tobacco smoking.

ABSTRACT:

Background

Although the harm to health from electronic nicotine delivery systems (ENDS) compared to smoked tobacco remains highly uncertain, society and governments still need to know the likely range of the relative harm to inform regulatory policies for ENDS and smoking.

Methods

We identified biomarkers with specificity of association with different disease groupings e.g., volatile organic compound (VOCs) for chronic obstructive pulmonary disease; and tobacco-specific N´-nitrosamines (TSNAs) and polycyclic aromatic hydrocarbons (PAHs) for all cancers. We conducted a review of recent studies (post January 2017) that compared these biomarkers between people exclusively using ENDS and those exclusively smoking tobacco. The percentage differences in these biomarkers, weighted

SUBMITTER: Wilson N 

PROVIDER: S-EPMC8577029 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature